Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Napredno
  • Upadacitinib response rates in...
  • Citiraj
  • Pošljite SMS
  • Pošljite email
  • Natisni
  • Izvozi zadetek
    • Izvozi v RefWorks
    • Izvozi v EndNoteWeb
    • Izvozi v EndNote
  • Permanent link
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

Show other versions (1)
Bibliografske podrobnosti
Main Authors: Coates, LC, Garrood, T, Gullick, N, Helliwell, P, Kent, T, Marks, J, Tillett, W, Kaur-Papadakis, D, Tahir, H, van Haaren, S, McInnes, I
Format: Journal article
Jezik:English
Izdano: Oxford University Press 2022
  • Zaloga
  • Opis
  • Other Versions (1)
  • Podobne knjige/članki
  • Knjižničarski pogled

Podobne knjige/članki

  • Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
    od: Coates, LC, et al.
    Izdano: (2021)
  • Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    od: Iain B. McInnes, et al.
    Izdano: (2022-10-01)
  • Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
    od: McGagh, D, et al.
    Izdano: (2020)
  • Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
    od: Loredana Frasca, et al.
    Izdano: (2018-09-01)
  • Treat-to-target in PsA: methods and necessity
    od: Dures, E, et al.
    Izdano: (2020)

Iskalne možnosti

  • Iskalna zgodovina
  • Napredno iskanje

Poišči več

  • Prelistaj katalog
  • Po abecedi
  • Explore Channels
  • Obvezna literatura
  • Novi knjige/članki

Potrebujete pomoč?

  • Navodila za iskanje
  • Vprašaj knjižničarja
  • Pogosta vprašanja